FindTrial
Sign In

Safety of intraoperative autologous blood transfusion in patients with osteosarcoma

Safety of intraoperative autologous blood transfusion in patients with osteosarcoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037773
Enrollment
Unknown
Registered
2020-09-01
Start date
2019-01-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteosarcoma

Interventions

case series:Autogenous blood

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients schedule for osteosarcoma resection, aged 10-65 years.

Exclusion criteria

Exclusion criteria: Associated with other malignant neoplastic diseases; fever or taking immunosuppressive drugs; with infectious disease.

Design outcomes

Primary

MeasureTime frame
Osteosarcoma cell;Osteosarcoma cell culture;—

Countries

China

Contacts

Public ContactWang Geng

Beijing Jishuitan Hospital

w_geng@163.com+86 13910676672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026